PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
10.21203/rs.3.rs-59508/v12020Real-world Efficacy and Safety of Dulaglutide in Korean Patients with Type 2 Diabetes Mellitus: A Retrospective Study in a Tertiary Referral CenterJee Hee Yoon, A Ram Hong, Wonsuk Choi, Ji Yong Park, Hee Kyung Kim, Ho-Cheol Kanghttps://www.researchsquare.com/article/rs-59508/v1, https://www.researchsquare.com/article/rs-59508/v1.html
Diabetes10.2337/db18-1180-p201867Supplement_1Efficacy and Safety of Long-Term Administration of Dapagliflozin for Japanese Patients with Type 2 Diabetes MellitusMASAHIRO YAMAZAKI, RYOSUKE SAKAI, TAKURO OKAMURA, MICHIAKI FUKUIhttps://diabetesjournals.org/diabetes/article/67/Supplement_1/1180-P/53963/Efficacy-and-Safety-of-Long-Term-Administration-of, https://diabetesjournals.org/diabetes/article/67/Supplement_1/1180-P/53963/Efficacy-and-Safety-of-Long-Term-Administration-of
Diabetes & Metabolic Syndrome: Clinical Research & Reviews10.1016/j.dsx.2021.01.0112021151385-389Real world study of short term efficacy, safety, and tolerability of canagliflozin 100 mg initiation in type 2 diabetes mellitus patients during hot humid Indian summerDebmalya Sanyal, Anirban Majumder, Sujoy Ghosh, Kaushik Pandithttps://api.elsevier.com/content/article/PII:S1871402121000138?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1871402121000138?httpAccept=text/plain
Diabetes, Obesity and Metabolism10.1111/dom.124032015172152-160A randomized, double‐blind, placebo‐controlled study on long‐term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long‐Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) studyA. Kashiwagi, H. Takahashi, H. Ishikawa, S. Yoshida, K. Kazuta, A. Utsuno, E. Ueyamahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.12403, https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12403, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/dom.12403, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12403/fullpdf
Diabetes & Metabolism Journal10.4093/dmj.2018.01342019435590Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical PracticeA Ram Hong, Bo Kyung Koo, Sang Wan Kim, Ka Hee Yi, Min Kyong Moonhttps://synapse.koreamed.org/pdf/10.4093/dmj.2018.0134, https://synapse.koreamed.org/DOIx.php?id=10.4093/dmj.2018.0134, http://e-dmj.org/upload/pdf/dmj-43-590.pdf
Diabetes, Obesity and Metabolism10.1111/dom.122352013165418-425Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extensionT. Kadowaki, K. Kondohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.12235, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12235/fullpdf
Expert Opinion on Pharmacotherapy10.1080/14656566.2020.18173882020223373-387Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Unohttps://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1817388
Diabetology International10.1007/s13340-021-00501-w2021124430-444Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)Hiroshi Maegawa, Kazuyuki Tobe, Ichiro Nakamura, Satoshi Unohttps://link.springer.com/content/pdf/10.1007/s13340-021-00501-w.pdf, https://link.springer.com/article/10.1007/s13340-021-00501-w/fulltext.html, https://link.springer.com/content/pdf/10.1007/s13340-021-00501-w.pdf
Endocrine Practice10.1016/j.eprac.2021.04.5962021276S60Abstract #1004035: Efficacy and Safety of Remogliflozin in Overweight and Obese Type 2 Diabetes Mellitus Patients in a Real-world SettingAjay Sinhahttps://api.elsevier.com/content/article/PII:S1530891X21007552?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1530891X21007552?httpAccept=text/plain
Chonnam Medical Journal10.4068/cmj.2021.57.3.2112021573211Real-World Efficacy and Safety of Dulaglutide in Korean Patients with Type 2 Diabetes Mellitus: A Retrospective Study in a Tertiary Referral CenterJee Hee Yoon, A Ram Hong, Wonsuk Choi, Ji Yong Park, Hee Kyung Kim, Ho-Cheol Kanghttps://cmj.ac.kr/pdf/10.4068/cmj.2021.57.3.211, https://cmj.ac.kr/DOIx.php?id=10.4068/cmj.2021.57.3.211, https://cmj.ac.kr/DOIx.php?id=10.4068/cmj.2021.57.3.211